Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | MVD | P53602 | 3/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CPT2 | P23786 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1286788 | 1.00 | HMGCR (0.50) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| SCHEMBL18376075 | 1.00 | HMGCR (0.50) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| Diphosphomelavonate SCHEMBL29398109 | 0.86 | MVD (0.64) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| Diphosphomelavonate SCHEMBL183248 | 0.86 | MVD (0.64) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| Diphosphomelavonate SCHEMBL3272270 | 0.86 | MVD (0.64) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| SCHEMBL15258419 | 0.84 | MVD (0.47) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| SCHEMBL14864445 | 0.84 | MVD (0.47) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| SCHEMBL17635391 | 0.84 | HMGCR (0.48) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| SCHEMBL12332332 | 0.82 | MVD (0.43) | HMGCRCHRM1TBXA2RADRA1AMVD | |
| SCHEMBL12189512 | 0.81 | MVD (0.49) | HMGCRCHRM1TBXA2RADRA1AMVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 857 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | AMYRIS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4698673-A1 | STRAINS AND METHODS FOR THE PRODUCTION OF MOGROSIDES | DSM IP Assets B.V. (NL) | 2026-02-25 | — | — | EP | claimed |
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-20250290103-A1 | NEROLIDOL SYNTHASE AND USE THEREOF | WUHAN HESHENG TECHNOLOGY CO., LTD. (CN) | 2025-09-18 | — | — | US | claimed |
| CN-119799757-B | Recombinant strain for producing squalene, construction method and application thereof | 中国农业科学院生物技术研究所 | 2025-06-10 | — | — | CN | claimed |
| CN-119979517-A | (-) -Alpha-bisabolol synthase mutant and application thereof | 武汉合生科技有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20250129394-A1 | CELLULAR ENGINEERING TO IMPROVE CANNABINOID PRODUCTION IN MICROBIAL CELLS | CELLIBRE, INC. | 2025-04-24 | — | — | US | claimed |
| US-20250129357-A1 | VALENCENE SYNTHASE MUTANT AND VALENCENE HIGH-YIELD STRAIN | WUHAN HESHENG TECHNOLOGY CO., LTD. (CN) | 2025-04-24 | — | — | US | claimed |
| CN-119842510-A | Recombinant yeast for producing bakuchiol, construction method and application thereof | 天津凯莱英生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-119799757-A | Recombinant strain for producing squalene, construction method and application thereof | 中国农业科学院生物技术研究所 | 2025-04-11 | — | — | CN | claimed |
| US-7927862-B2 | Production of isoprenoids | ARKION LIFE SCIENCES, LLC (US) | 2011-04-19 | — | — | US | claimed |
| US-7927861-B2 | Production of isoprenoids | ARKION LIFE SCIENCES, LLC (US) | 2011-04-19 | — | — | US | claimed |
| US-20110059515-A1 | PRODUCTION OF ISOPRENOIDS | Amyris, Inc. | 2011-03-10 | — | — | US | claimed |
| US-20110059516-A1 | PRODUCTION OF ISOPRENOIDS | Amyris, Inc. | 2011-03-10 | — | — | US | claimed |
| US-7842497-B2 | microorganism capable of making an isoprenoid by increasing the supply of a precursor to an isoprenoid biosynthetic pathway and conversion of the precursor to isopentenyl pyrophosphate; production of farnesol and geranylgeraniol | BIO-TECHNICAL RESOURCES, A DIVISION OF ARKION LIFE SCIENCES, LLC (US) | 2010-11-30 | — | — | US | claimed |
| US-7838279-B2 | Production of isoprenoids | BIO-TECHNICAL RESOURCES, A DIVISION OF ARKION LIFE SCIENCES, LLC (US) | 2010-11-23 | — | — | US | claimed |
| US-20100035329-A1 | recombinant yeast comprising one or more heterologous nucleic acid molecules encoding an enzyme that converts converts hydroxymethylglutaryl-CoA to mevalonic acid, mevalonic acid to phosphomevalonic acid, phosphomevalonic acid to phosphomevalonate, phosphomevalonate to isopentenyl pyrophosphate | Amyris, Inc. | 2010-02-11 | — | — | US | claimed |
| WO-2009064910-A2 | DIMETHYLOCTANE AS AN ADVANCED BIOFUEL | SYNTHETIC GENOMICS, INC. (US) | 2009-05-22 | — | — | WO | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| WO-1995013058-A1 | HALOGENATED MEVALONATE COMPOSITIONS AND USES THEREOF IN RAS-DEPENDENT CELL GROWTH | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-05-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | MAX, JUND, MYCBP | HMGCR 3895/4885CHRM1 4660/4885TBXA2R 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.